About this Journal Submit a Manuscript Table of Contents
The Scientific World Journal
Volume 2012 (2012), Article ID 895765, 6 pages
http://dx.doi.org/10.1100/2012/895765
Review Article

A Review for Solitary Plasmacytoma of Bone and Extramedullary Plasmacytoma

1Radiation Oncology Clinic, Okmeydani Training and Research Hospital, Ministry of Health, Istanbul, Turkey
2Department of Radiation Oncology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey
3Department of Radiation Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey
4Department of Radiation Oncology, Faculty of Medicine, Ege University, Izmir, Turkey

Received 10 May 2011; Accepted 22 December 2011

Academic Editor: Kenneth C. Anderson

Copyright © 2012 Sevil Kilciksiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Dimopoulos, L. A. Moulopoulos, A. Maniatis, and R. Alexanian, “Solitary plasmacytoma of bone and asymptomatic multiple myeloma,” Blood, vol. 96, no. 6, pp. 2037–2044, 2000. View at Scopus
  2. M. A. Dimopoulos and G. Hamilos, “Solitary bone plasmacytoma and extramedullary plasmacytoma,” Current Treatment Options in Oncology, vol. 3, no. 3, pp. 255–259, 2002. View at Scopus
  3. M. Ozsahin, R. W. Tsang, P. Poortmans et al., “Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 1, pp. 210–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Tong, T. W. Griffin, G. E. Laramore, et al., “Solitary plasmacytoma of bone and soft tissues,” Radiology, vol. 135, pp. 195–198, 1980.
  5. E. Wiltshaw, “The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis,” Medicine, vol. 55, no. 3, pp. 217–238, 1976. View at Scopus
  6. G. Frizzera, “Castleman's disease and related disorders,” Seminars in Diagnostic Pathology, vol. 5, pp. 346–364, 1988.
  7. C. Alexiou, R. J. Kau, H. Dietzfelbinger et al., “Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts,” Cancer, vol. 85, no. 11, pp. 2305–2314, 1999. View at Scopus
  8. P. Galieni, M. Cavo, A. Pulsoni et al., “Clinical outcome of extramedullary plasmacytoma,” Haematologica, vol. 85, no. 1, pp. 47–51, 2000. View at Scopus
  9. R. H. Liebross, C. S. Ha, J. D. Cox, D. Weber, K. Delasalle, and R. Alexanian, “Clinical course of solitary extramedullary plasmacytoma,” Radiotherapy and Oncology, vol. 52, no. 3, pp. 245–249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Hu and J. Yahalom, “Radiotherapy in the management of plasma cell tumors,” Oncology, vol. 14, no. 1, pp. 101–112, 2000.
  11. G. M. Dores, O. Landgren, K. A. McGlynn, R. E. Curtis, M. S. Linet, and S. S. Devesa, “Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004,” British Journal of Haematology, vol. 144, no. 1, pp. 86–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. G. M. Durie, R. A. Kyle, A. Belch et al., “Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation,” Hematology Journal, vol. 4, no. 6, pp. 379–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. B. G. M. Durie and S. E. Salmon, “A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival,” Cancer, vol. 36, no. 3, pp. 842–854, 1975. View at Scopus
  14. P. Di Micco and B. Di Micco, “Up-date on solitary plasmacytoma and its main differences with multiple myeloma,” Experimental Oncology, vol. 27, no. 1, pp. 7–12, 2005. View at Scopus
  15. M. Dimopoulos, E. Terpos, R. L. Comenzo et al., “International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma,” Leukemia, vol. 23, no. 9, pp. 1545–1556, 2009. View at Scopus
  16. M. X. He, M. H. Zhu, Y. M. Zhang, Q. G. Fu, and L. L. Wu, “Solitary plasmacytoma of spine: a clinical, radiologjc and pathologic study of 13 cases,” Zhonghua Bing Li Xue Za Zhi, vol. 38, no. 5, pp. 307–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Kim, R. J. Hicks, A. Wirth et al., “Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 3, pp. 740–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Schirrmeister, A. K. Buck, L. Bergmann, S. N. Reske, and M. Bommer, “Positron emission tomography (PET) for staging of solitary plasmacytoma,” Cancer Biotherapy and Radiopharmaceuticals, vol. 18, no. 5, pp. 841–845, 2003. View at Scopus
  19. R. A. Kyle, “Monoclonal gammopathy of undetermined significance and solitary plasmacytoma: implications for progression to overt multiple myeloma,” Hematology, vol. 11, no. 1, pp. 71–87, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. T. W. Bolek, R. B. Marcus, and N. P. Mendenhall, “Solitary plasmacytoma of bone and soft tissue,” International Journal of Radiation Oncology Biology Physics, vol. 36, no. 2, pp. 329–333, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Holland, D. A. Trenkner, T. H. Wasserman, and B. Fineberg, “Plasmacytoma: treatment results and conversion to myeloma,” Cancer, vol. 69, no. 6, pp. 1513–1517, 1992. View at Scopus
  22. S. Kumar, R. Fonseca, A. Dispenzieri et al., “Prognostic value of angiogenesis in solitary bone plasmacytoma,” Blood, vol. 101, no. 5, pp. 1715–1717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Frassica, F. J. Frassica, M. F. Schray, F. H. Sim, and R. A. Kyle, “Solitary plasmacytoma of bone: Mayo Clinic experience,” International Journal of Radiation Oncology Biology Physics, vol. 16, no. 1, pp. 43–48, 1989. View at Scopus
  24. S. Kilciksiz, O. K. Celik, Y. Pak et al., “Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group—Sarcoma Working Party,” American Journal of Hematology, vol. 83, no. 9, pp. 702–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Knobel, A. Zhouhair, R. W. Tsang et al., “Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study,” BMC Cancer, vol. 6, article 118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. H. Liebross, C. S. Ha, J. D. Cox, D. Weber, K. Delasalle, and R. Alexanian, “Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 41, no. 5, pp. 1063–1067, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. Weber, “Solitary bone and extramedullary plasmacytoma,” American Society of Hematology Education Book, pp. 373–376, 2005.
  28. N. A. Mayr, B. C. Wen, D. H. Hussey et al., “The role of radiation therapy in the treatment of solitary plasmacytomas,” Radiotherapy and Oncology, vol. 17, no. 4, pp. 293–303, 1990. View at Scopus
  29. R. Soutar, H. Lucraft, G. Jackson, et al., “Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma,” Clinical Oncology, vol. 16, pp. 405–413, 2004.
  30. H. Y. Liu, X. M. Luo, S. H. Zhou, and Z. J. Zheng, “Prognosis and expression of lambda light chains in solitary extramedullary plasmacytoma of the head and neck: two case reports and a literature review,” Journal of International Medical Research, vol. 38, no. 1, pp. 282–288, 2010. View at Scopus
  31. C. M. Mendenhall, T. L. Thar, and R. R. Million, “Solitary plasmacytoma of bone and soft tissue,” International Journal of Radiation Oncology Biology Physics, vol. 6, no. 11, pp. 1497–1501, 1980. View at Scopus
  32. R. W. Tsang, M. K. Gospodarowicz, M. Pintilie, et al., “Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome,” International Journal of Radiation Oncology Biology Physics, vol. 50, pp. 113–120, 2001.
  33. R. Bataille and J. Sany, “Solitary myeloma: clinical and prognostic features of a review of 114 cases,” Cancer, vol. 48, no. 3, pp. 845–851, 1981. View at Scopus
  34. M. A. Dimopoulos, J. Goldstein, L. Fuller, K. Delasalle, and R. Alexanian, “Curability of solitary bone plasmacytoma,” Journal of Clinical Oncology, vol. 10, no. 4, pp. 587–590, 1992. View at Scopus
  35. R. B. Wilder, C. S. Ha, J. D. Cox, D. Weber, K. Delasalle, and R. Alexanian, “Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone,” Cancer, vol. 94, no. 5, pp. 1532–1537, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. S. Susnerwala, J. H. Shanks, S. S. Banerjee, J. H. Scarffe, W. T. Farrington, and N. J. Slevin, “Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases,” British Journal of Cancer, vol. 75, no. 6, pp. 921–927, 1997. View at Scopus
  37. G. S. Folk, S. L. Abbondanzo, E. L. Childers, and R. D. Foss, “Plasmablastic lymphoma: a clinicopathologic correlation,” Annals of Diagnostic Pathology, vol. 10, no. 1, pp. 8–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Soutar, H. Lucraft, G. Jackson, et al., “Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma,” British Journal of Haematology, vol. 124, pp. 717–726, 2004.
  39. N. Sundaresan, A. A. Steinberger, F. Moore et al., “Indications and results of combined anterior-posterior approaches for spine tumor surgery,” Journal of Neurosurgery, vol. 85, no. 3, pp. 438–446, 1996. View at Scopus
  40. P. Galieni, M. Cavo, G. Avvisati et al., “Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?” Annals of Oncology, vol. 6, no. 7, pp. 687–691, 1995. View at Scopus
  41. M. A. Dimopoulos, C. Kiamouris, and L. A. Moulopoulos, “Solitary plasmacytoma of bone and extramedullary plasmacytoma,” Hematology, vol. 13, no. 6, pp. 1249–1257, 1999. View at Scopus
  42. L. Tournier-Rangeard, M. Lapeyre, P. Graff-Caillaud et al., “Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: a dose greater than 45 gy to the target volume improves the local control,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 4, pp. 1013–1017, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Strojan, E. Šoba, J. Lamovec, and A. Munda, “Extramedullary plasmacytoma: Clinical and histopathologic study,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 3, pp. 692–701, 2002. View at Publisher · View at Google Scholar
  44. R. H. Liebross, C. S. Ha, J. D. Cox, D. Weber, K. Delasalle, and R. Alexanian, “Clinical course of solitary extramedullary plasmacytoma,” Radiotherapy and Oncology, vol. 52, no. 3, pp. 245–249, 1999. View at Publisher · View at Google Scholar
  45. M. W. Chao, P. Gibbs, A. Wirth, G. Quong, M. J. Guiney, and K. H. Liew, “Radiotherapy in the management of solitary extramedullary plasmacytoma,” Internal Medicine Journal, vol. 35, no. 4, pp. 211–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. H. S. Glazer, J. H. Niemeyer, D. M. Balfe, et al., “Neck neoplasms: MR imaging—part II: posttreatment evaluation,” Radiology, vol. 160, pp. 349–354, 1986.
  47. R. Lufkin and W. Hanafee, “MRI of the head and neck,” Magnetic Resonance Imaging, vol. 6, no. 1, pp. 69–88, 1988. View at Scopus
  48. D. D. Stark, A. A. Moss, and G. Gamsu, “Magnetic resonance imaging of the neck—part I: normal anatomy,” Radiology, vol. 150, no. 2, pp. 447–454, 1984. View at Scopus
  49. M. W. M. van den Brekel, H. V. Stel, J. A. Castelijns et al., “Cervical lymph node metastasis: assessment of radiologic criteria,” Radiology, vol. 177, no. 2, pp. 379–384, 1990. View at Scopus
  50. A. N. Hasso and K. D. Brown, “Use of gadolinium chelates in MR imaging of lesions of the extracranial head and neck,” Journal of Magnetic Resonance Imaging, vol. 3, no. 1, pp. 247–263, 1993. View at Scopus
  51. R. Jyothirmayi, V. P. Gangadharan, M. K. Nair, and B. Rajan, “Radiotherapy in the treatment of solitary plasmacytoma,” British Journal of Radiology, vol. 70, pp. 511–516, 1997. View at Scopus
  52. M. Hughes, R. Soutar, H. Lucraft, R. Owen, and J. Bird, Guidelines on the Diagnosis and Management of Solitary Plasmacytoma of Bone, Extramedullary Plasmacytoma and Multiple Solitary Plasmacytomas: 2009 Update, British Committee for Standards in Haematology, London, UK, 2009.
  53. M. A. Knowling, A. R. Harwood, and D. E. Bergsagel, “Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone,” Journal of Clinical Oncology, vol. 1, no. 4, pp. 255–262, 1983. View at Scopus
  54. L. Y. Shih, P. Dunn, W. M. Leung, W. J. Chen, and P. N. Wang, “Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone,” British Journal of Cancer, vol. 71, no. 1, pp. 128–133, 1995. View at Scopus
  55. A. Avilés, J. Huerta-Guzmán, S. Delgado, A. Fernández, and J. C. Díaz-Maqueo, “Improved outcome in solitary bone plasmacytomata with combined therapy,” Hematological Oncology, vol. 14, no. 3, pp. 111–117, 1996. View at Scopus
  56. M. C. Delauche-Cavallier, J. D. Laredo, M. Wybier et al., “Solitary plasmacytoma of the spine: long-term clinical course,” Cancer, vol. 61, no. 8, pp. 1707–1714, 1988. View at Scopus
  57. Suzanne R Fanning, DO; Chief Editor: Emmanuel C Besa. Plasmacytoma, Extramedullary, http://emedicine.medscape.com/article/207233-follow up.